Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice

Abstract

The tumor suppressor SMAD4, also known as DPC4, deleted in pancreatic cancer, is a central mediator of TGF-β signaling. It was previously shown that mice homozygous for a null mutation of Smad4 (Smad4−/−) died prior to gastrulation displaying impaired extraembryonic membrane formation and endoderm differentiation. Here we show that Smad4+/− mice began to develop polyposis in the fundus and antrum when they were over 6–12 months old, and in the duodenum and cecum in older animals at a lower frequency. With increasing age, polyps in the antrum show sequential changes from hyperplasia, to dysplasia, in-situ carcinoma, and finally invasion. These alterations are initiated by a dramatic expansion of the gastric epithelium where Smad4 is expressed. However, loss of the remaining Smad4 wild-type allele was detected only in later stages of tumor progression, suggesting that haploinsufficiency of Smad4 is sufficient for tumor initiation. Our data also showed that overexpression of TGF-β1 and Cyclin D1 was associated with increased proliferation of gastric polyps and tumors. These studies demonstrate that Smad4 functions as a tumor suppressor in the gastrointestinal tract and also provide a valuable model for screening factors that promote or prevent gastric tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM and Zwijsen A . 1999 Development 126: 1631–1642

  • Correa P . 1992 Cancer Res 52: 6735–6740

  • Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ . 1998 Nature 396: 177–180

  • Fox JG, Dangler CA, Whary MT, Edelman W, Kucherlapati R and Wang TC . 1997 Cancer Res 57: 3972–3978

  • Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R and Wang TC . 1996 Gastroenterology 110: 155–166

  • Friedl W, Kruse R, Uhlhaas S, Stolte M, Schartmann B, Keller KM, Jungck M, Stern M, Loff S, Back W, Propping P and Jenne DE . 1999 Genes Chromosomes Cancer 25: 403–406

  • Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK and Markowitz S . 1999 Cancer Res 59: 320–324

  • Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE . 1996 Science 271: 350–353

  • Heldin CH, Miyazono K and ten Dijke P . 1997 Nature 390: 465–471

  • Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura DY and Stone EM . 1998a Am J Hum Genet 62: 1129–1136

  • Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, Stone EM and Aaltonen LA . 1998b Science 280: 1086–1088

  • Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H and Tahara E . 1992 Cancer Res 52: 295–300

  • Jarvinen H and Franssila KO . 1984 Gut 25: 792–800

  • Kinzler KW and Vogelstein B . 1996 Cell 87: 159–170

  • Ko TC, Yu W, Sakai T, Sheng H, Shao J, Beauchamp RD and Thompson EA . 1998 Oncogene 16: 3445–3454

  • Markowitz SD and Roberts AB . 1996 Cytokine Growth Factor Rev 7: 93–102

  • Massague J . 1990 Annu Rev Cell Biol 6: 597–641

  • Massague J . 1998 Ann Rev Biochem 67: 753–791

  • Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, Hishima T, Koike M, Shitara N, Iwama T, Utsunomiya J, Kuroki T and Mori T . 1999 Oncogene 18: 3098–3103

  • Moss SF . 1998 Aliment Pharmacol Ther 12: Suppl 1 91–109

  • Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, et al. 1995 Cancer Res 55: 5545–5547

  • Naef M, Ishiwata T, Friess H, Buchler MW, Gold LI and Korc M . 1997 Int J Cancer 71: 131–137

  • Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T and Takahashi T . 1996 Cancer Res 56: 2718–2720

  • Nomura M and Li E . 1998 Nature 393: 786–790

  • Okamoto A, Jiang W, Kim SJ, Spillare EA, Stoner GD, Weinstein IB and Harris CC . 1994 Proc Natl Acad Sci USA 91: 11576–11580

  • Oswald F, Lovec H, Moroy T and Lipp M . 1994 Oncogene 9: 2029–2036

  • Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB . 1994 Proc Natl Acad Sci USA 91: 8772–8776

  • Pisani P, Parkin DM and Ferlay J . 1993 Int J Cancer 55: 891–903

  • Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM and Stampfer MR . 1997 Mol Cell Biol 17: 2458–2467

  • Schulze A, Zerfass K, Spitkovsky D, Henglein B and Jansen-Durr P . 1994 Oncogene 9: 3475–3482

  • Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA and Kern SE . 1996 Cancer Res 56: 2527–2530

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sirard C, de la Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A, Schwartz L, Kern SE, Rossant J and Mak TW . 1998 Genes Dev 12: 107–119

  • Tahara E . 1995 World J Surg 19: 484–488; discussion 489–490

  • Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF and Taketo MM . 1998 Cell 92: 645–656

  • Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Terashima M, Eda Y and Satodate R . 1996 J Pathol 180: 371–377

  • Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ and Wakefield LM . 1998 Nat Med 4: 802–807

  • Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D and Donehower LA . 1998 EMBO J 17: 4657–4667

  • Vogelstein B . 1990 Nature 348: 681–682

  • Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL and Robertson EJ . 1998 Cell 92: 797–808

  • Weinstein M, Yang X, Li C, Xu X, Gotay J and Deng CX . 1998 Proc Natl Acad Sci USA 95: 9378–9383

  • Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Ichiyoshi Y and Sugimachi K . 1996 Cancer 77: 1628–1633

  • Yang HK, Kang SH, Kim YS, Won K, Bang YJ and Kim SJ . 1999a Oncogene 18: 2213–2219

  • Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP and Deng CX . 1999b Development 126: 1571–1580

  • Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB and Deng C . 1999c EMBO J 18: 1280–1291

  • Yang X, Li C, Xu X and Deng C . 1998 Proc Natl Acad Sci USA 95: 3667–3672

  • Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E . 1989 Int J Cancer 44: 394–398

  • Zhu Y, Richardson JA, Parada LF and Graff JM . 1998 Cell 94: 703–714

Download references

Acknowledgements

We thank W Qiao for technical assistance and A Roberts and L Ferrin for critically reading the manuscript and helpful discussion.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, X., Brodie, S., Yang, X. et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19, 1868–1874 (2000). https://doi.org/10.1038/sj.onc.1203504

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203504

Keywords

This article is cited by

Search

Quick links